Moximed - Gilde Healthcare

Moximed

Venture&Growth
Location

Hayward (CA), USA
Zürich, Switzerland

Knee Replacing Implant
Since: 2011
Venture&Growth

US-based MedTech company providing a medical implant to patients suffering from osteoarthritis of the knee.

Moximed is commercializing the KineSpring®, a medical implant for patients suffering from osteoarthritis of the knee. Osteoarthritis is the most common form of arthritis and affects an estimated 150 million people worldwide. The KineSpring® is designed to unload excess weight on the knee. It is therefore suited for a growing population of patients that are too young to receive knee replacement surgery. To date, over 600 patients have received a KineSpring® implant.

After Gilde invested in Moximed, the company started to commercialize its products in Europe and established a multinational user-base. It has further initiated clinical studies for market registration in the US and optimized the implant, procedure and surgical instruments. Moximed is based in Hayward, California.

More Moximed news

Gilde Healthcare portfolio company Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study

Gilde Healthcare company Moximed raises $40 Million to advance world’s first Implantable Shock Absorber for Knee Osteoarthritis

Moximed Closes Oversubscribed $50MM Financing Round

Moximed: First Patient Treated in US Study of Atlas® System for Unicompartmental Knee Osteoarthritis

Moximed’s Atlas™ Knee System Improves Pain Scores and Returns Function to Pre-Arthroplasty Patients with Medial Knee Osteoarthritis

Moximed Announces CE Mark and First Commercial Use of Atlas Knee System

Moximed closes $33 million financing round

Moximed Completes Enrollment of KineSpring System US SOAR Study in Patients with Knee Osteoarthritis

Moximed Initiates US Clinical Study with KineSpring® System in Patients with Knee Osteoarthritis

Moximed’s Implantable Knee Spring Successfully Reduces Pain and Quickly Returns Normal Function

Gilde Healthcare Partners invests in Moximed, Inc.